Sucralfate
Carafate, Sucralfate (sucralfate) is an unknown pharmaceutical. Sucralfate was first approved as Carafate on 1982-01-01. It is used to treat duodenal ulcer, esophagitis, gastritis, pneumonia, and stomach ulcer amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Carafate, Sucralfate (discontinued: Sucralfate)
Drug Products
FDA
EMA
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| carafate | New Drug Application | 2024-05-21 |
| sucralfate | ANDA | 2026-09-02 |
| sucralfate oral suspension | ANDA | 2026-01-06 |
| sulcralfate | ANDA | 2010-05-27 |
| varecell intensive liposome doublecream | unapproved drug other | 2021-09-07 |
Indications
FDA
EMA
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
321 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myalgia | D063806 | — | M79.1 | — | — | — | 1 | 3 | 4 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | 1 | 2 | 3 |
| Dyspepsia | D004415 | EFO_0008533 | K30 | — | — | — | 1 | 1 | 2 |
| Hernia | D006547 | — | K40-K46 | — | — | — | 1 | 1 | 2 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 1 | — | 1 | — | 2 |
| Facial pain | D005157 | — | R51.9 | — | — | — | 1 | 1 | 2 |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | — | — | — | 1 | — | 1 |
| Ventilator-associated pneumonia | D053717 | EFO_1001865 | J95.851 | — | — | — | 1 | — | 1 |
| Coronary artery disease | D003324 | — | I25.1 | — | — | — | 1 | — | 1 |
| Emergencies | D004630 | — | — | — | — | — | 1 | — | 1 |
Show 10 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postoperative pain | D010149 | — | G89.18 | — | — | 1 | — | 6 | 7 |
| Mucositis | D052016 | EFO_1001898 | — | — | — | 1 | — | 3 | 4 |
| Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | — | 1 | 1 | — | 3 | 4 |
| Sleep wake disorders | D012893 | — | G47 | — | — | 1 | — | 2 | 3 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | 1 | — | 2 | 3 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | 1 | — | 2 | 3 |
| Head and neck neoplasms | D006258 | — | — | — | — | 2 | — | — | 2 |
| Chondrocalcinosis | D002805 | — | M11.2 | — | — | 1 | — | — | 1 |
| Human influenza | D007251 | EFO_0007328 | J11.1 | — | 1 | 1 | — | — | 1 |
| Influenza in birds | D005585 | — | J09.X | — | 1 | 1 | — | — | 1 |
Show 6 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 2 | — | — | 4 | 6 |
| Neoplasms | D009369 | — | C80 | — | 1 | — | — | 5 | 6 |
| Stomatitis | D013280 | EFO_1001904 | K12.1 | — | 1 | — | — | 3 | 4 |
| Neck pain | D019547 | — | M54.2 | — | 1 | — | — | 3 | 4 |
| Depression | D003863 | — | F33.9 | — | 1 | — | — | 3 | 4 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | 1 | — | — | 2 | 3 |
| Covid-19 | D000086382 | — | U07.1 | — | 1 | — | — | 2 | 3 |
| Rectal neoplasms | D012004 | — | — | — | 1 | — | — | 1 | 2 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | — | — | 1 | 2 |
| Respiratory aspiration | D053120 | EFO_1001839 | — | — | 1 | — | — | 1 | 2 |
Show 21 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 4 | — | — | — | 6 | 10 |
| Wounds and injuries | D014947 | — | T14.8 | 1 | — | — | — | 4 | 5 |
| Spinal cord injuries | D013119 | EFO_1001919 | — | 1 | — | — | — | 1 | 2 |
| Hemorrhage | D006470 | MP_0001914 | R58 | 1 | — | — | — | 1 | 2 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | — | — | — | — | 1 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | — | — | — | — | 1 |
| Eosinophilic esophagitis | D057765 | EFO_0004232 | K20.0 | 1 | — | — | — | — | 1 |
| Malaria | D008288 | EFO_0001068 | B54 | 1 | — | — | — | — | 1 |
| Falciparum malaria | D016778 | EFO_0007444 | B50 | 1 | — | — | — | — | 1 |
| Thoracic injuries | D013898 | — | S20-S29 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | — | 20 | 20 |
| Muscle spasticity | D009128 | — | — | — | — | — | — | 10 | 10 |
| Cerebral palsy | D002547 | — | G80 | — | — | — | — | 9 | 9 |
| Low back pain | D017116 | — | M54.5 | — | — | — | — | 9 | 9 |
| Syndrome | D013577 | — | — | — | — | — | — | 8 | 8 |
| Back pain | D001416 | — | M54 | — | — | — | — | 8 | 8 |
| Pain | D010146 | EFO_0003843 | R52 | — | — | — | — | 7 | 7 |
| Rotator cuff injuries | D000070636 | — | M75.1 | — | — | — | — | 6 | 6 |
| Myofascial pain syndromes | D009209 | EFO_1001054 | — | — | — | — | — | 5 | 5 |
| Shoulder pain | D020069 | — | M25.51 | — | — | — | — | 5 | 5 |
Show 237 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Sucralfate |
| INN | sucralfate |
| Description | Sucralfate, sold under various brand names, is a medication used to treat stomach ulcers, gastroesophageal reflux disease (GERD), radiation proctitis, and stomach inflammation and to prevent stress ulcers. Its usefulness in people infected by H. pylori is limited. It is used by mouth (for upper GIT ulcers) and rectally (for radiation proctitis).
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O=S(=O)(OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O)O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O |
Identifiers
| PDB | — |
| CAS-ID | 54182-58-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3989780 |
| ChEBI ID | — |
| PubChem CID | 6398525 |
| DrugBank | DB00364 |
| UNII ID | XX73205DH5 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Carafate – Allergan
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Carafate – Warner Chilcott
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
Sucralfate
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,515 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use